Navigation Links
First national study of diving-related injuries
Date:8/3/2008

ge of 18 in this country* and millions of others who dive for fun. All of whom, McKenzie says, may want to learn more about the sport to lessen their chances of injury.

Experts say most people are hurt trying to do flips off of diving boards, especially back flips*. If your child wants to learn how to do them, try to enroll them in a program with a qualified instructor, and be sure they only use a diving board when a life guard is on duty.

*Diving Related Injuries in Children <20 Years Old Treated in Emergency Departments in the United States: 1990-2006, Pediatrics Volume 122, Number 2, August 2008

**** (COLUMBUS, Ohio) The thrill of flipping and jumping into water has become common practice among children and adolescents as they dive into more than eight million swimming pools across the United States. Competitive divers strive to gracefully enter the water without making a splash however these athletes, including the future Beijing 2008 Olympians, are not immune to the increase in diving-related injuries over the past two decades. Not only are competitive divers at risk for injury, but recreational divers are also being treated in emergency departments for diving-related injuries.

A new study conducted by researchers at the Center for Injury Research and Policy (CIRP) of The Research Institute at Nationwide Children's Hospital, found that the most common injuries while diving were to the head, neck and face.

Published in the August issue of Pediatrics, study findings revealed that an estimated 111,000 diving-related injuries to persons under the age of 19 were treated in emergency departments from 1990 through 2006. Lacerations and soft tissue injuries were the most common diagnoses, representing more than 58 percent of all injuries. Collision with the diving board or platform was the leading cause of injury the likelihood of collision with the diving board dramatically increased when a diver attempt
'/>"/>

Contact: Marti Leitch
mleitch@mediasourcetv.com
614-932-9950
Nationwide Children's Hospital
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. Handa Pharmaceuticals Announces Submission of its First-to-File ANDA for AstraZenecas SEROQUEL(R) XR
2. Sweden to Receive Scandinavia's First TomoTherapy System : Lund University Hospital to Offer Swedish Cancer Patients the Most Advanced Image-Guided Radiation Therapy Treatments
3. Trubion Pharmaceuticals Provides Announcement Dates for Second Quarter and First Six Months Earnings Conference Call
4. Chindex International to Report Fiscal 2009 First Quarter Financial Results
5. Cyberonics Announces Conference Call to Discuss Fiscal Year 2009 First Quarter Financial Results
6. Safe Pesticides Now First in Poisonings
7. Encision Reports First Fiscal Quarter Results
8. MTBC First Medical Billing Company in the U.S. To Offer Automated Real-time Adjudication of Claims
9. STERIS Corporation Announces Fiscal 2009 First Quarter Results
10. FGX International Reports Strong Sales and Earnings Growth for the Second Quarter and First Six Months of 2008
11. Hanger Orthopedic Group, Inc. Beats First Call Q2 EPS Estimates by $0.05 on 13% Sales Growth and 57.2% Growth in Net Income
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
First national study of diving-related injuries
First national study of diving-related injuries
Other Medicine News:Health News:University of Texas Study Details Lengthy Payment Delays for Medicare Part D Prescription Drug Claims, Confirming Need for Legislative Fix 2Health News:University of Texas Study Details Lengthy Payment Delays for Medicare Part D Prescription Drug Claims, Confirming Need for Legislative Fix 3Health News:Cleveland Clinic Press Releases Journal-Writing Book 'Write for Life: Healing Body, Mind, and Spirit Through Journal Writing' by Sheppard B. Kominars, Ph.D. 2Health News:Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007 2Health News:Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007 3Health News:Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007 4Health News:Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007 5Health News:Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007 6Health News:Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007 7Health News:Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007 8Health News:Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007 9Health News:Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007 10Health News:Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007 11Health News:Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007 12Health News:Regional Center of Orange County Expands Family Support Resources to Meet Growing Needs 2Health News:Counseling Boosts Alzheimer's Caregivers' Health 2
Breaking Medicine Technology:Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 2Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 3Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 4ARKRAY, Inc. Receives FDA 510k Clearance on the Assure(R) Platinum Auto-Code Blood Glucose Monitoring System 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 4STALLERGENES is Granted a Marketing Authorization for Oralair 28R 29 in Europe 14985 1STALLERGENES is Granted a Marketing Authorization for Oralair 28R 29 in Europe 14985 2STALLERGENES is Granted a Marketing Authorization for Oralair 28R 29 in Europe 14985 3Clemente 26apos 3Bs Anatomy Rohen 26apos 3Bs Photographic Anatomy and Moore 26apos 3Bs Clinical Anatomy Customizable Apps Now Available on App Store 62182 1Clemente 26apos 3Bs Anatomy Rohen 26apos 3Bs Photographic Anatomy and Moore 26apos 3Bs Clinical Anatomy Customizable Apps Now Available on App Store 62182 2Clemente 26apos 3Bs Anatomy Rohen 26apos 3Bs Photographic Anatomy and Moore 26apos 3Bs Clinical Anatomy Customizable Apps Now Available on App Store 62182 3Clemente 26apos 3Bs Anatomy Rohen 26apos 3Bs Photographic Anatomy and Moore 26apos 3Bs Clinical Anatomy Customizable Apps Now Available on App Store 62182 4Clemente 26apos 3Bs Anatomy Rohen 26apos 3Bs Photographic Anatomy and Moore 26apos 3Bs Clinical Anatomy Customizable Apps Now Available on App Store 62182 5Tough yet stiff deer antler is materials scientists dream 10910 1Tough yet stiff deer antler is materials scientists dream 10910 2